Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 5062

1.

Efficacy of glimepiride/metformin fixed-dose combination vs metformin uptitration in type 2 diabetic patients inadequately controlled on low-dose metformin monotherapy: A randomized, open label, parallel group, multicenter study in Korea.

Kim HS, Kim DM, Cha BS, Park TS, Kim KA, Kim DL, Chung CH, Park JH, Jang HC, Choi DS.

J Diabetes Investig. 2014 Nov;5(6):701-708. Epub 2014 Mar 16.

PMID:
25422771
[PubMed - as supplied by publisher]
2.

Management of type 2 diabetes mellitus in self-motivated patients: optimized diet, exercise, and medication for weight loss and cardiometabolic fitness.

Nadeau DA.

Phys Sportsmed. 2014 Nov;42(4):49-59. doi: 10.3810/psm.2014.11.2091.

PMID:
25419888
[PubMed - in process]
3.

Saxagliptin efficacy and safety in patients with type 2 diabetes mellitus stratified by cardiovascular disease history and cardiovascular risk factors: analysis of 3 clinical trials.

Cook W, Minervini G, Bryzinski B, Hirshberg B.

Postgrad Med. 2014 Oct;126(6):19-32. doi: 10.3810/pgm.2014.10.2818.

PMID:
25414932
[PubMed - in process]
4.

Postprandial C-peptide to glucose ratio as a predictor of β-cell function and its usefulness for staged management of type 2 diabetes.

Lee EY, Hwang S, Lee SH, Lee YH, Choi AR, Lee Y, Lee BW, Kang ES, Ahn CW, Cha BS, Lee HC.

J Diabetes Investig. 2014 Sep;5(5):517-524. Epub 2014 Feb 12.

PMID:
25411619
[PubMed - as supplied by publisher]
Free PMC Article
5.

Efficacy and tolerability of albiglutide versus placebo and versus pioglitazone over 1 year in people with type 2 diabetes currently taking metformin and glimepiride: HARMONY 5.

Home P, Shamanna P, Stewart M, Yang F, Miller M, Perry C, Carr MC.

Diabetes Obes Metab. 2014 Nov 19. doi: 10.1111/dom.12414. [Epub ahead of print]

PMID:
25406730
[PubMed - as supplied by publisher]
6.

Effects of metformin and insulin on h9c2 rat cardiomyocytes in cell culture with elevated glucose levels.

Lee L, Tucci MA, Benghuzzi HA.

Biomed Sci Instrum. 2014;50:367-74.

PMID:
25405446
[PubMed - in process]
7.

In metformin-treated type 2 diabetes mellitus, weekly dulaglutide was noninferior to daily liraglutide for HbA1c levels.

Morey-Vargas OL, Shah P.

Ann Intern Med. 2014 Nov 18;161(10):JC9. doi: 10.7326/0003-4819-161-10-201411180-02009. No abstract available.

PMID:
25402542
[PubMed - in process]
8.

Effect of vildagliptin on hsCRP and arterial stiffness in patients with type 2 diabetes mellitus.

Zografou I, Sampanis C, Gkaliagkousi E, Iliadis F, Papageorgiou A, Doukelis P, Vogiatzis K, Douma S.

Hormones (Athens). 2014 Nov 5. doi: 10.14310/horm.2002.1512. [Epub ahead of print]

PMID:
25402372
[PubMed - as supplied by publisher]
9.

Helicobacter pylori Infection Decreases Metformin Tolerance in Patients with Type 2 Diabetes Mellitus.

Huang Y, Sun J, Wang X, Tao X, Wang H, Tan W.

Diabetes Technol Ther. 2014 Nov 12. [Epub ahead of print]

PMID:
25391019
[PubMed - as supplied by publisher]
10.

Vitamins And Type 2 Diabetes Mellitus.

Roxana VR, Laura GL, Elina MC, Donají BA.

Endocr Metab Immune Disord Drug Targets. 2014 Nov 10. [Epub ahead of print]

PMID:
25388747
[PubMed - as supplied by publisher]
11.

Metformin in Cancer Treatment and Prevention.

Morales DR, Morris AD.

Annu Rev Med. 2014 Nov 6. [Epub ahead of print]

PMID:
25386929
[PubMed - as supplied by publisher]
12.

Virtual Systems Pharmacology (ViSP) software for simulation from mechanistic systems-level models.

Ermakov S, Forster P, Pagidala J, Miladinov M, Wang A, Baillie R, Bartlett D, Reed M, Leil TA.

Front Pharmacol. 2014 Oct 22;5:232. doi: 10.3389/fphar.2014.00232. eCollection 2014.

PMID:
25374542
[PubMed]
Free PMC Article
13.

Postprandial Dynamics of Plasma Glucose, Insulin, and Glucagon in Patients with Type 2 Diabetes Treated with Saxagliptin Plus Dapagliflozin Add-On to Metformin Therapy.

Hansen L, Iqbal N, Ekholm E, Cook W, Hirshberg B.

Endocr Pract. 2014 Nov 4:1-29. [Epub ahead of print]

PMID:
25370334
[PubMed - as supplied by publisher]
14.

Fixed-Dose Combination Therapy in Type 2 Diabetes Mellitus.

Blonde L, Juan ZT, Bolton P.

Endocr Pract. 2014 Nov 4:1-32. [Epub ahead of print]

PMID:
25370323
[PubMed - as supplied by publisher]
15.

Lifestyle factors associated with type 2 diabetes and use of different glucose-lowering drugs: cross-sectional study.

Ulrichsen SP, Mor A, Svensson E, Larsen FB, Thomsen RW.

PLoS One. 2014 Nov 4;9(11):e111849. doi: 10.1371/journal.pone.0111849. eCollection 2014.

PMID:
25369331
[PubMed - in process]
Free PMC Article
16.

Allele and genotype frequency of a genetic variant in ataxia telangiectasia mutated gene affecting glycemic response to metformin in South Indian population.

Vilvanathan S, Gurusamy U, Mukta V, Das AK, Chandrasekaran A.

Indian J Endocrinol Metab. 2014 Nov;18(6):850-4. doi: 10.4103/2230-8210.119944.

PMID:
25364682
[PubMed]
Free PMC Article
17.

Efficacy and safety of autologous bone marrow derived hematopoietic stem cell transplantation in patients with type 2 DM: A 15 months follow-up study.

Bhansali A, Upreti V, Walia R, Gupta V, Bhansali S, Sharma RR, Grover S, Marwaha N, Khandelwal N.

Indian J Endocrinol Metab. 2014 Nov;18(6):838-45. doi: 10.4103/2230-8210.140257.

PMID:
25364680
[PubMed]
Free PMC Article
18.

A Perspective Overview of Clinically Approved Oral Antidiabetic Agents for the Treatment of Type 2 Diabetes Mellitus.

He ZX, Zhou ZW, Yang Y, Yang T, Pan SY, Qiu JX, Zhou SF.

Clin Exp Pharmacol Physiol. 2014 Oct 31. doi: 10.1111/1440-1681.12332. [Epub ahead of print]

PMID:
25360831
[PubMed - as supplied by publisher]
19.

Characteristics and short-term outcomes of patients with type 2 diabetes mellitus treated with canagliflozin in a real-world setting.

Buysman EK, Chow W, Henk HJ, Rupnow MF.

Curr Med Res Opin. 2014 Nov 12:1-7. [Epub ahead of print]

PMID:
25356602
[PubMed - as supplied by publisher]
20.

Economic simulation of canagliflozin and sitagliptin treatment outcomes in patients with type 2 diabetes mellitus with inadequate glycemic control.

Lafeuille MH, Grittner AM, Gravel J, Bailey RA, Martin S, Garber L, Duh MS, Lefebvre P.

J Med Econ. 2014 Nov 7:1-13. [Epub ahead of print]

PMID:
25350645
[PubMed - as supplied by publisher]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk